Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 370.63Cr 431.03Cr 55Cr 48Cr 45Cr 41Cr 77Cr 5.24TCr 78Cr 522.55Cr 204.74Cr 2.62TCr 206.25Cr 201.76Cr 8.75TCr P/E 2026 *
8.15x
P/E 2027 * 7.23x
Enterprise Value 370.63Cr 431.03Cr 55Cr 48Cr 45Cr 41Cr 77Cr 5.24TCr 78Cr 522.55Cr 204.74Cr 2.62TCr 206.25Cr 201.76Cr 8.75TCr EV / Sales 2026 *
0.53x
EV / Sales 2027 * 0.49x
Free-Float
45.7%
Yield 2026 *
5.53%
Yield 2027 * 6.22%
09/07 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
29/06 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
29/06 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
12/06 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
26/05 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
27/04 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
30/03 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
27/03 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
27/03 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
27/03 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
06/02 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
13/01 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Li Siu Bun from the Positions as an Independent Non-Executive Director, Chairman of the Audit Committee of the Board and A Member of Each of the Remuneration Committee of the Board and the Strategy and Planning Committee CI
30/12 Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
1 day-1.17%
1 week-3.30%
Current month-4.40%
1 month+2.91%
3 months-13.05%
6 months-24.21%
Current year-23.70%
1 week 3.3
Extreme 3.305
3.57
1 month 3.29
Extreme 3.29
3.64
Current year 3.07
Extreme 3.07
4.56
1 year 3.07
Extreme 3.07
5.45
3 years 3.07
Extreme 3.07
7.03
5 years 3.07
Extreme 3.07
9.28
10 years 3.07
Extreme 3.07
16
Manager TitleAgeSince
Chief Executive Officer 58 04/06/2025
Comptroller/Controller/Auditor 48 04/06/2025
Corporate Secretary 37 09/07/2026
Director TitleAgeSince
Director/Board Member 67 10/02/2011
Director/Board Member 69 12/06/2018
Director/Board Member 82 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
-1.17%-3.30%-34.53%-51.79% 56Cr
-0.70%-2.79%-9.05%-6.89% 1.35TCr
-0.81%-3.21%+4.93%+2.37% 511.35Cr
-0.99%-4.67%-31.60%-56.22% 511.02Cr
-0.12%+0.90%+5.57%-29.80% 418.23Cr
-1.13%-2.80%-7.89%-5.93% 369.41Cr
-0.93%-4.47%-3.06%+3.55% 353.67Cr
-0.64%-2.33%-3.66%+15.21% 346.09Cr
-0.44%-1.00%-12.80%-15.78% 248.05Cr
+0.71%-2.34%-2.38%+44.27% 186.89Cr
Average -0.62%+0.05%-9.45%-10.10% 435.4Cr
Weighted average by Cap. -0.67%-0.30%-7.89%-9.99%

Financials

2026 *2027 *
Net sales 698.2Cr 811.97Cr 103.48Cr 90Cr 84Cr 77Cr 144.15Cr 9.87TCr 146.57Cr 984.39Cr 385.69Cr 4.94TCr 388.54Cr 380.08Cr 16TCr 756.3Cr 879.53Cr 112.09Cr 97Cr 91Cr 83Cr 156.14Cr 11TCr 158.77Cr 1.07TCr 417.78Cr 5.35TCr 420.87Cr 411.7Cr 18TCr
Net income 45Cr 53Cr 6.74Cr 5.84Cr 5.46Cr 4.99Cr 9.38Cr 642.49Cr 9.54Cr 64Cr 25Cr 321.59Cr 25Cr 25Cr 1.07TCr 51Cr 60Cr 7.61Cr 6.6Cr 6.17Cr 5.63Cr 11Cr 725.9Cr 11Cr 72Cr 28Cr 363.33Cr 29Cr 28Cr 1.21TCr
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,951
Date Price Change Volume
11/26/11 HK$3.365 -1.17% 12,28,000
10/26/10 HK$3.405 +1.19% 7,12,000
07/26/07 HK$3.365 -0.59% 7,64,000
06/26/06 HK$3.385 -1.46% 3,54,000
05/26/05 HK$3.435 -0.29% 4,54,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.894CNY
Average target price
4.601CNY
Spread / Average Target
+59.01%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1666 Stock